HAVCR2 and cancer: Interestingly, TIM-3 was also found to be expressed on liver cancer cells, where it promoted tumor progression via NFκB/IL-6/STAT-3 pathway, and cervical cancer, where TIM-3 expression was associated with shorter overall survival and advanced cancer stages, and promoted migration and invasion of cancer cells [101, 102].